Table 1.
The relationship of lncRNA DGCR5 and clinical characteristics in 70 ESCC patients.
| Clinicopathological features | N | Expression of DGCR5 | χ2 | P value | |
|---|---|---|---|---|---|
| High (n = 41) | Low (n = 29) | ||||
| Gender | 1.349 | 0.2452 | |||
| Male | 51 | 32 | 19 | ||
| Female | 19 | 9 | 10 | ||
| Age (t/a) | 0.1501 | 0.6985 | |||
| ≤60 | 26 | 16 | 10 | ||
| >60 | 44 | 25 | 19 | ||
| Invasion range | 5.011 | 0.0252 | |||
| T1 + T2 | 15 | 5 | 10 | ||
| T3 | 55 | 36 | 19 | ||
| TNM stage | 11.27 | 0.0008 | |||
| I + II | 34 | 13 | 21 | ||
| III+IVA | 36 | 28 | 8 | ||
| Metastasis (lymph) | 11.32 | 0.0008 | |||
| No | 25 | 8 | 17 | ||
| Yes | 45 | 33 | 12 | ||
UICC/AJCC TNM classification (8th edition), *P < 0.05, which was considered as a significant difference.